Next Article in Journal
Listening to the Voice of the Hospitalized Child: Comparing Children’s Experiences to Their Parents
Previous Article in Journal
Acute Appendicitis as the Initial Presentation of Kawasaki Disease Shock Syndrome in Children
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Children
Volume 9
Issue 12
10.3390/children9121821
children-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Mean Platelet Volume in Neonatal Sepsis: Meta-Analysis of Observational Studies

by
Carlos J. Toro-Huamanchumo
1,
Cielo Cabanillas-Ramirez
2,3,
Carlos Quispe-Vicuña
3,4,
Jose A. Caballero-Alvarado
5,
Darwin A. León-Figueroa
3,6,
Nicolás Cruces-Tirado
7 and
Joshuan J. Barboza
3,8,*
1
Escuela de Medicina, Universidad Cesar Vallejo, Trujillo 13007, Peru
2
Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas, Lima 15023, Peru
3
Unidad de Revisiones Sistemáticas y Meta-Análisis, Tau-Relaped Group, Trujillo 13007, Peru
4
Sociedad Científica San Fernando, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru
5
Facultad de Medicina, Universidad Privada Antenor Orrego, Trujillo 13007, Peru
6
Facultad de Medicina Humana, Universidad de San Martín de Porres, Chiclayo 14000, Peru
7
Facultad de Ciencias de la Salud, Universidad Señor de Sipán, Chiclayo 14006, Peru
8
Vicerrectorado de Investigación, Universidad Norbert Wiener, Lima 15046, Peru
*
Author to whom correspondence should be addressed.
Children 2022, 9(12), 1821; https://doi.org/10.3390/children9121821
Submission received: 5 October 2022 / Revised: 21 November 2022 / Accepted: 22 November 2022 / Published: 25 November 2022
(This article belongs to the Section Pediatric Infectious Diseases)
Browse Figures
Review Reports Versions Notes

Abstract

:
Introduction: Early onset neonatal sepsis (EONS), particularly in preterm sepsis, is a potentially fatal issue. Evaluation of mean platelet volume (MPV) as an EONS predictor was the goal. Methods: Four databases were used to conduct a systematic evaluation of cohort and case–control studies. Up till the end of October 2022, 137 articles were found utilizing the search method. Following the review, 12 studies were included. Leukocytes, MPV, platelets, gender, birth weight, gestational age, mortality, and C-reactive protein (CRP) were all taken into account while analyzing the prediction of EONS. Inverse-variance methodology and the random-effects model were used. Using GRADE, the evidence’s quality was evaluated. Results: Neonatal patients with sepsis had significantly higher MPV levels than do neonates without sepsis (MD 1.26; 95% CI 0.89–1.63; p < 0.001). An increased MPV during the first 24 h postpartum was associated with high CRP values and high risk of neonatal mortality. In the investigations, the MPV cutoff for sepsis patients was 9.95 (SD 0.843). Overall certainty of the evidence was very low. Conclusions: The increased MPV during the first 24 h postpartum may be predictive of EONS and mortality. Future studies are warranted.

Graphical Abstract

1. Introduction

A potentially fatal issue is EONS. It is responsible for up to 30 to 50 percent of all newborn fatalities in underdeveloped nations [1].
Additionally, neonatal sepsis (NS) is regarded as a significant contributor to newborn morbidity and mortality on a global scale [2]. It generates an economic impact, for example, the annual cost of deaths in newborns that are due to sepsis in the United States is 1.97 billion dollars [3]. EONS develops within the newborn’s first 72 h of life [4]. There is a certain degree of difficulty in its diagnosis due to the non-specific clinical manifestations in this type of patient. [5]. This has led to the search for predictors of sepsis. An example is the mean platelet volume (MPV), which could help diagnose EONS [6].
Likewise, some neonatal and maternal risk factors would lead to the development of sepsis in the newborn, such as, low birth weight, chorioamnionitis, prematurity and premature rupture of membranes [7]. The association between neonatal sepsis and other factors, such as gestational age, mode of delivery, sex, and age of the neonate, is still not well defined [8]. The diagnosis of NS is difficult to establish, mainly due to the non-specific clinical features of the patient, where there is temperature instability, tachypnea, hypotension, hypotonia, and abdominal distention [9]. However, some acute phase reactants and inflammatory mediators are predictors of sepsis, such as procalcitonin (PCT), interleukins 6 and 8, C-reactive protein (CRP), and fibrinogen [10]. Due to their significant negative predictive value, platelets have recently been employed as a biomarker for the exclusion of newborn sepsis [11].
According to studies in recent years, among these mediators is the MPV, which could act as a predictor of EONS [12]. The main mechanisms that platelets offer to identify sepsis are the disturbed platelet production during sepsis and the measurement of MPV as a marker of the mean size of circulating platelets in the whole blood count [13,14]. Therefore, the present study aims to evaluate MPV as a predictor of EONS.

2. Materials and Methods

2.1. Data Sources and Searches

From March to June 2022, we searched PubMed, Embase, Web of Science (WOS), and Scopus. We applied the PRISMA 2020 criteria for reporting this systematic review [15]. The key search terms used were “mean platelet volume” and “neonatal sepsis”. Abstracts from cohort and case–control studies that assessed MPV as a predictor of EONS were included. There was no restriction based on the year of publication.
Reviews, case reports and case series studies, editorials, meta-analysis, and letters were excluded.

2.2. Study Selection

In this study, we employed the P-O criteria, considering the Population (Newborns with an early onset neonatal sepsis diagnosis) and the Outcome (MPV measured by mean and standard deviation). Cohort and case–control studies that evaluated mean platelet volume as a predictor of EONS were included in the study. Case-control studies that matched the first two criteria were also included. We omitted narrative and systematic reviews, experiments on animals, clinical trials, case reports, abstracts from conferences, and letters.
Using Rayyan QCRI (https://rayyan.qcri.org/ (accessed on 20 June 2022)), two writers (C.J.T.H. and C.C.R.) independently reviewed the titles and abstracts in accordance with the inclusion and exclusion criteria [16]. The full texts of chosen pertinent studies were searched for in-depth examination. Conflicts were settled by consensus and, if necessary, input from a third author (J.J.B.). Selected articles were stored using the Endnote 20 program.

2.3. Outcomes

The outcome was the Mean platelet volume (fL), measured in mean and standard deviation (SD).

2.4. Data Extraction

Two authors (NCT and JJB) separately extracted the information using the prescribed forms. Consensus was used to resolve disagreements, and a third author was consulted if necessary. The initial author’s name, the year, the study’s design, the participants’ number, the target MPV (fL), the CRP, the mortality, and the study’s results were all gathered. Conflicts were settled with the assistance of a third author.

2.5. Risk of Bias (RoB) Assessment

The RoB was then assessed by two investigators. Finally, the Newcastle Ottawa Scale (NOS) tool was used to examine both cohort and case–control studies independently. This scale was created to evaluate the quality of nonrandomized trials to incorporate quality judgments into meta-analysis interpretation. In the interpretation of meta-analyses, the NOS evaluated quality based on content, design, and simplicity of use. It is made up of eight pieces that are separated into three dimensions (comparison, selection, type of study).

2.6. Statistical Analysis

For meta-analysis, random-effects models and inverse-variance method were applied. For continuous outcomes, the effects of mean platelet volume (MPV) and other characteristics were characterized using mean differences (MD) with 95 percent confidence intervals (95% CI). The I2 statistic was used to look at study heterogeneity: 0–30 percent means low, 30–60 percent means moderate, and >60 percent means high. The primary outcomes were broken down into subgroups based on gestational age (preterm versus term newborns). The R 3.5.1 meta library’s metabin and metacont functions were utilized.

2.7. Quality of Evidence

GRADE was evaluated for the certainty of evidence [17]. A summary results table was created utilizing the results using the GRADEpro software (McMaster University and Evidence Prime Inc., Hamilton, ON, Canada).

3. Results

3.1. Selection of Studies

In first place, a total of 137 records were found in the four databases of which 69 duplicates were eliminated. Second, 68 records were selected by title and abstract, and then just 29 records were evaluated in full text. The 37 excluded did not follow our inclusion or exclusion criteria, or were case reports, letters to editor, narrative review or editorial. Finally, 12 studies were ultimately included in the systematic review [18,19,20,21,22,23,24,25,26,27,28,29]. (Figure 1).

3.2. Characteristics of Included Studies

Included studies (Table 1) according to the design were nine case–control studies and only one cohort study conducted in countries such as Egypt, Turkey, Iran, and India. The most common concept regarding the definition of sepsis among all studies was: “Proven sepsis” [18,19,20,21,22,23,24,25,26,27], as clinical signs of sepsis with isolation of pathogen in blood, cerebrospinal fluid (CSF), or urine; and, “Probable sepsis” [18,19,20,21,22,23,24,25,26,27], as clinical signs of sepsis without isolated pathogen, with one or more of the following criteria: (a) maternal fever, foul-smelling fluid, prolonged rupture of membranes more than 12 h, gastric polymorph count of more than 6/hpf; (b) positive sepsis screen with 2 of the following 4 parameters: total leukocyte count <5000/mm3, the ratio of band cells to total neutrophils equal to or greater than 0.2, CRP greater than or equal to 0.6 mg/dl, micro Erythrocyte Sedimentation Rate (ESR) greater than or equal to 15 mm at the end of the first hour; and (c) radiological evidence of pneumonia. Most studies agrees that high MPV is predictive of early neonatal sepsis and can function as an adequate biomarker.

3.3. Risk of Bias Analysis

After the evaluation with the Newcastle Ottawa Scale tool, four studies [19,21,23,25] showed a high risk of bias, and six showed a low level of risk of bias according to the assessment.

3.4. Effects of Mean Platelet Volume in Sepsis

We identified that the MPV is significantly higher in neonates with sepsis (MD 1.26; 95% CI 0.89–1.63; p < 0.001; Figure 2), compared with neonates without sepsis.

3.5. Cut-Off and Diagnosis Accuracy between Studies

The cut-off of MPV in patients with sepsis among the studies was 9.95 (SD 0.84). Only four studies had a sensitivity greater than 80% [18,22,25,26]. Similarly, six studies had a specificity greater than 80% [18,21,24,25,27,29]. The Area under curve (AUC) of most studies was greater than 0.6 [18,20,21,22,23,24,25], and two studies [27,28], was less than 0.5 (Table 2).

3.6. Quality of Evidence

We assess the quality of evidence using the GRADE tool (Table 3). Overall certainty of the evidence was very low. The risk of bias decreases by two levels because there are more than two studies with a high risk of bias. Additionally, the inconsistency was decreased by two levels because heterogeneity is higher than 60%. The indirectness and impression were not serious.

4. Discussion

Our study found an increase in MPV in the first 24 h in neonates with sepsis compared to without sepsis group. Therefore, elevated MPV values are predictive of EONS. In addition, we noted an increase of mortality and increased CRP values in patients with neonatal sepsis.
Blood culture is the gold standard for diagnosing newborn sepsis, which has some inefficiencies, such as a high false positive rate (due to contamination) and possible difficulty in obtaining results within 48 to 72 h [30]. Due to the deficiencies above, it was decided to look for alternatives. Here, the possibility of using inflammatory mediators appears, as in the case of MPV, which allows the diagnosis, follow-up, and prediction of the severity of sepsis in neonates [31].
In the pathophysiology of sepsis, there will be an alteration in the coagulation cascade, which will allow the release of multiple pro-and anti-inflammatory cytokines, leading to thrombus formation [32]. This will cause fibrinolytic and fibrinogenic substances to be depleted, leading to further platelet destruction. Finally, the bone marrow will increase the production of young platelets, which are larger and functionally more active, expressing themselves in an increase in vascular endothelial growth factor (VEGF) [33]. The bone marrow will then express itself in an increase in MPV, thus predicting the onset of sepsis.
Platelets have a significant role in sepsis-induced coagulopathy in septic newborns. P-selectin, which is expressed on the surface of platelets during systemic inflammation, enhances platelet adherence to leukocytes and platelet aggregation in addition to tissue factor expression on monocytes [34]. In septic infants, platelet consumption and thrombus development through active endothelium cause thrombocytopenia [35]. C-reactive protein reaches its peak after fifty hours and helps complement bind to foreign or damaged cells in response to inflammation. In addition to clinical evidence, CRP, a non-specific illness response, can aid in the diagnosis of septicemia [36].
It should be mentioned that no previous systematic reviews were found with which this work can be compared. On the other hand, we searched four databases, after which we included ten studies, and, in addition, we assessed the risk of bias using the NOS tool. Regarding the statistical analysis, our study analyzed the continuous variables with the mean difference and standard deviation according to the homogeneity of the measurement factor. Additionally, the random-effects model was applied.
The Importance of our findings lies in the fact that MPV is routinely reported as part of the complete blood count. However, a midpoint for EONS prediction could not be found because the studies reported MPV values with different measurement techniques.
Most of the studies evaluated reported values above the established cut-off, which may be associated with the high sensitivity and specificity reported among the studies. With the values established as an average, it is possible to have an estimated cut-off for evaluating patients with a potential diagnosis of neonatal sepsis [37]. Other studies also reported cut-off values in other population settings in sepsis [38,39,40].
Likewise, the low cost and easy availability makes the MPV a marker with greater significance. Another critical point to highlight is the homogeneity of the studies, nine of which were of the case–control type, allowing greater homogeneity in the groups studied. Associated factors, such as prematurity or low birth weight, were considered in very few studies, so their true significance could not be determined.
The study has some limitations. First, observational studies are subject to confounding variables, thus increasing statistical heterogeneity between studies, and may influence the true overall effect. Second, there is a very low certainty of the evidence, which limits an adequate interpretation despite the significant effect. However, this certainty of the evidence is not related to interventions but as a predictor.

5. Conclusions

In conclusion, with the results of this study, we can affirm that increased MPV may be used as a predictor of EONS, which would potentially allow us to avoid excessive antibiotic use and unnecessary hospitalizations.

Author Contributions

Conceptualization, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., N.C.-T., J.J.B. and J.A.C.-A.; methodology, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., N.C.-T., J.J.B. and J.A.C.-A.; software, C.C.-R.; validation, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., N.C.-T., J.J.B. and J.A.C.-A.; formal analysis, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., N.C.-T., J.J.B. and J.A.C.-A.; investigation, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., N.C.-T., J.J.B. and J.A.C.-A.; resources, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., N.C.-T., J.J.B. and J.A.C.-A.; data curation, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., N.C.-T., J.J.B. and J.A.C.-A.; writing—original draft preparation, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., N.C.-T., J.J.B. and J.A.C.-A.; writing—review and editing, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., N.C.-T., J.J.B. and J.A.C.-A. visualization, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., J.J.B. and J.A.C.-A.; supervision, C.C.-R. and J.J.B.; project administration, C.C.-R., C.Q.-V., D.A.L.-F., C.J.T.-H., J.J.B. and J.A.C.-A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dündar, B.; Çakmak, B.D.; Özgen, G.; Taşöz, F.N.; Güçlü, T.; Ocakoglu, G. The association of platelet indices and adverse neonatal outcomes in pregnancies complicated with preterm premature rupture of membranes. J. Turk. Ger. Gynecol. Assoc. 2016, 17, S228. [Google Scholar]
  2. Rajaratnam, J.K.; Marcus, J.R.; Flaxman, A.D.; Wang, H.; Levin-Rector, A.; Dwyer, L.; Costa, M.; Lopez, A.D.; Murray, C.J. Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970–2010: A systematic analysis of progress towards Millennium Development Goal 4. Lancet 2010, 375, 1988–2008. [Google Scholar] [CrossRef] [PubMed]
  3. Sharma, D.; Farahbakhsh, N.; Shastri, S.; Sharma, P. Biomarkers for diagnosis of neonatal sepsis: A literature review. J. Matern. Fetal Neonatal. Med. 2018, 31, 1646–1659. [Google Scholar] [CrossRef] [PubMed]
  4. Koroglu, M.; Terzi, H.A.; Gurol, G.; Demiray, T.; Ozbek, A.; Hafizoglu, T. Early detection of sepsis in newborn clinic, is it possible? Clin. Biochem. 2014, 47, 781. [Google Scholar] [CrossRef]
  5. Wang, J.; Wang, Z.; Zhang, M.; Lou, Z.; Deng, J.; Li, Q. Diagnostic value of mean platelet volume for neonatal sepsis: A systematic review and meta-analysis. Medicine 2020, 99, e21649. [Google Scholar] [CrossRef]
  6. Pamudji, K.M.; Kardana, I.M. Diagnostic value of mean platelet volume in neonatal sepsis. Paediatr. Indones. 2019, 59, 289–293. [Google Scholar] [CrossRef] [Green Version]
  7. Cekmez, Y.; Güleçoğlu, M.D.; Özcan, C.; Karadeniz, L.; Kiran, G. The utility of maternal mean platelet volume levels for early onset neonatal sepsis prediction of term infants. Ginekol. Pol. 2017, 88, 312–314. [Google Scholar] [CrossRef] [Green Version]
  8. Gray, A.; Sharara, F. Global and regional sepsis and infectious syndrome mortality in 2019: A systematic analysis. Lancet Glob. Health 2022, 10 (Suppl. 1), S2. [Google Scholar] [CrossRef]
  9. Eichberger, J.; Resch, E.; Resch, B. Diagnosis of Neonatal Sepsis: The Role of Inflammatory Markers. Front. Pediatr. 2022, 10, 840288. [Google Scholar] [CrossRef]
  10. Mari, J.; Kajlik, R.; Gajda, A.; Kiss, J.; Gyurkovits, Z. Use of antibiotics in suspected early-onset neonatal sepsis. Orv. Hetil. 2022, 163, 431–437. [Google Scholar] [CrossRef]
  11. Iroh Tam, P.Y.; Bendel, C.M. Diagnostics for neonatal sepsis: Current approaches and future directions. Pediatr. Res. 2017, 82, 574–583. [Google Scholar] [CrossRef] [PubMed]
  12. Hudon, R.E.; Leung, V.H.; Petit, S.; Banach, D.B. Hospital Readmissions Among Infants Diagnosed with Early-Onset Neonatal Sepsis in Connecticut. J. Pediatr. Infect. Dis. Soc. 2022, 11, 242–247. [Google Scholar] [CrossRef] [PubMed]
  13. Budak, Y.U.; Polat, M.; Huysal, K. The use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: A systematic review. Biochem. Med. 2016, 26, 178–193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Eicher, J.D.; Lettre, G.; Johnson, A.D. The genetics of platelet count and volume in humans. Platelets 2018, 29, 125–130. [Google Scholar] [CrossRef] [PubMed]
  15. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: 343 an updated guideline for reporting systematic reviews. BMJ 2021, 372. [Google Scholar] [CrossRef]
  16. Ouzzani, M.; Hammady, H.; Fedorowicz, Z.; Elmagarmid, A. Rayyan-a web and mobile app for systematic reviews. Syst. Rev. 2016, 5, 210. [Google Scholar] [CrossRef] [Green Version]
  17. Aguayo-Albasini, J.L.; Flores-Pastor, B.; Soria-Aledo, V. Sistema GRADE: Clasificación de la calidad de la evidencia 347 y graduación de la fuerza de la recomendación. Cir. Esp. 2014, 92, 82–88. [Google Scholar] [CrossRef]
  18. Shaaban, H.A.; Safwat, N. Mean platelet volume in preterm: A predictor of early onset neonatal sepsis. J. Matern. Fetal Neonatal. Med. 2018, 33, 206–211. [Google Scholar] [CrossRef]
  19. Oncel, M.Y.; Ozdemir, R.; Yurttutan, S.; Canpolat, F.E.; Erdeve, O.; Oguz, S.S.; Uras, N.; Dilmen, U. Mean Platelet Volume in Neonatal Sepsis. J. Clin. Lab. Anal. 2012, 26, 493–496. [Google Scholar] [CrossRef]
  20. Omran, A.; Maaroof, A.; Saleh, M.H.; Abdelwahab, A. Salivary C-reactive protein, mean platelet volume and neutrophillymphocyte ratio as diagnostic markers for neonatal sepsis. J. Pediatr. (Rio J.) 2018, 94, 82–87. [Google Scholar] [CrossRef]
  21. Mousa, S.O.; Moustafa, A.N.; Aly, H.M. Prognostic value of red cell distribution width, platelet parameters, and the hematological scoring system in neonatal sepsis. Egypt J. Haematol. 2019, 44, 183–189. [Google Scholar] [CrossRef]
  22. Karabulut, B.; Alatas, S.O. Diagnostic Value of Neutrophil to Lymphocyte Ratio and Mean Platelet Volume on Early Onset Neonatal Sepsis on Term Neonate. J. Pediatr. Intensive Care 2021, 10, 143–147. [Google Scholar] [CrossRef] [PubMed]
  23. Madani, S.H.; Amiri, S.; Khazaei, S.; Erfan, M.B.K.; Rostami-Far, Z.; Tarlan, M.; Akya, A.; Azizi, A.; Izadi, B.; Shaveisi-Zadeh, J. Platelet indices as useful indicators of neonatal sepsis. J. Evol. Med. Dent. Sci. 2019, 8, 1612–1617. [Google Scholar] [CrossRef]
  24. Hanaganahalli, S.B.; Sreeram, S.; Bompada, M.; Kuppannagari, S.K.; Suresh, P.K.; Philipose, C.S. Is MPV a Predictive Marker for Neonatal Sepsis? A Pilot Study. J. Pediatr. Hematol. Oncol. 2018, 40, 548–552. [Google Scholar] [CrossRef]
  25. Catal, F.; Tayman, C.; Tonbul, A.; Akça, H.; Kara, S.; Tatli, M.M.; Oztekin, O.; Bilici, M. Mean platelet volume (MPV) may simply predict the severity of sepsis in preterm infants. Clin. Lab. 2014, 60, 1193–1200. [Google Scholar] [CrossRef]
  26. Aydın, B.; Dilli, D.; Zenciroğlu, A.; Karadag, N.; Beken, S.; Okumuş, N. Mean Platelet Volume and Uric Acid Levels in Neonatal Sepsis. Indian J. Pediatr. 2014, 81, 1342–1346. [Google Scholar] [CrossRef]
  27. Aydemir, C.; Aydemir, H.; Kokturk, F.; Kulah, C.; Mungan, A.G. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis. BMC Pediatr. 2018, 18, 253. [Google Scholar] [CrossRef] [Green Version]
  28. Shalaby, M.M.; Sobeih, A.A.; Abdulghany, W.E.; Behiry, E.G.; Ismail, Y.M.; Abd-El-Aziz, M.A. Mean platelet volume and serum uric acid in neonatal sepsis: A case-control study. Ann. Med. Surg. 2017, 20, 97–102. [Google Scholar] [CrossRef]
  29. Yao, Y.; Tu, Y.; Lu, Q. Values of C-reactive protein, percentage of neutrophils and mean platelet volume in early diagnosis of neonatal sepsis. Zhongguo Dang Dai Er Ke Za Zhi 2015, 17, 425–429. (In Chinese) [Google Scholar]
  30. Gialamprinou, D.; Mitsiakos, G.; Katsaras, G.N.; Kontovazainitis, C.G.; Karagianni, P.; Roilides, E.; Kenet, G. Neonatal Sepsis and Hemostasis. Diagnostics 2022, 12, 261. [Google Scholar] [CrossRef]
  31. Burgunder, L.; Heyrend, C.; Olson, J.; Stidham, C.; Lane, R.D.; Workman, J.K.; Larsen, G.Y. Medication and Fluid Management of Pediatric Sepsis and Septic Shock. Paediatr. Drugs 2022, 24, 193–205. [Google Scholar] [CrossRef] [PubMed]
  32. Akhmaltdinova, L.; Kolesnichenko, S.; Lavrinenko, A.; Kadyrova, I.; Avdienko, O.; Panibratec, L. Influence of Pathogen Type on Neonatal Sepsis Biomarkers. Int. J. Inflam. 2021, 2021, 1009231. [Google Scholar] [CrossRef] [PubMed]
  33. Siavashi, V.; Asadian, S.; Taheri-Asl, M.; Keshavarz, S.; Zamani-Ahmadmahmudi, M.; Nassiri, S.M. Endothelial Progenitor Cell Mobilization in Preterm Infants with Sepsis Is Associated with Improved Survival. J. Cell. Biochem. 2017, 118, 3299–3307. [Google Scholar] [CrossRef] [PubMed]
  34. Tunjungputri, R.N.; van de Heijden, W.; Urbanus, R.T.; de Groot, P.G.; van der Ven, A.; de Mast, Q. Higher platelet reactivity and platelet-monocyte complex formation in Gram-positive sepsis compared to Gram-negative sepsis. Platelets 2017, 28, 595–601. [Google Scholar] [CrossRef] [PubMed]
  35. Iba, T.; Levy, J. Inflammation and thrombosis: Roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J. Thromb. Haemost. 2018, 16, 231–241. Available online: https://pubmed.ncbi.nlm.nih.gov/29193703/ (accessed on 20 June 2022). [CrossRef] [Green Version]
  36. Mair, R.J.; Joy, A.H.; Finney, H.; Weaver, A. Creating an algorithm for requesting C-reactive protein in the emergency department. Eur. J. Emerg. Med. 2010, 17, 125–126. [Google Scholar] [CrossRef]
  37. Cai, N.; Chen, Z.Q.; Tao, M.; Fan, W.T.; Liao, W. Mean platelet volume and red blood cell distribution width is associated with prognosis in premature neonates with sepsis. Open Med. (Wars) 2021, 16, 1175–1181. [Google Scholar] [CrossRef]
  38. Vélez-Paez, J.L.; Velarde-Montero, C.; Irigoyen-Mogro, E.; Vélez-Páez, P.; Cifuentes-López, P.; Vélez, J.W.; Flores, J.L.R.A.; Barboza, J.J. Mean platelet volume as a predictor of mortality in patients with sepsis: Systematic review and meta-analysis. Infectio 2020, 24, 162–168. [Google Scholar] [CrossRef] [Green Version]
  39. Vélez-Páez, J.L.; Armendáriz-Carvajal, A.C.; Rueda-Barragán, F.E.; Castro-Reyes, E.E.; Escola-Brito, A.C.; Chambergo-Michilot, D.; Castillo-Sancho, S.A.; Hilario-Gomez, M.M.; Barboza, J.J. Utility of cytometric parameters and indices as predictors of mortality in patients with sepsis. Infectio 2021, 25, 153–158. [Google Scholar] [CrossRef]
  40. Toro-Huamanchumo, C.J.; Barboza, J.J.; Pinedo-Castillo, L.; Barros-Sevillano, S.; Gronerth-Silva, J.K.; Gálvez-Díaz, N.d. Maternal factors associated with prematurity in pregnant women from a public hospital in Trujillo, Peru. Rev. Del Cuerpo Med. Hosp. Nac. Almanzor Aguinaga Asenjo 2021, 14, 287–290. [Google Scholar] [CrossRef]
Children 09 01821 g001 550
Figure 1. PRISMA flow chart of the studies selection process.
Figure 1. PRISMA flow chart of the studies selection process.
Children 09 01821 g001
Children 09 01821 g002 550
Figure 2. MPV in neonates with and without EONS [18,19,20,21,22,23,24,25,26,27,28,29].
Figure 2. MPV in neonates with and without EONS [18,19,20,21,22,23,24,25,26,27,28,29].
Children 09 01821 g002
Table
Table 1. Characteristics of Included studies.
Table 1. Characteristics of Included studies.
Author, YearCountryStudy DesignDefinition of SepsisMPV (Mean, SD)CRP (Mean, SD)Mortality (n, %)ConclusionsRisk of Bias
Shaaban, 2018
[18]		EgyptCohort studyClinical diagnosis10.23 ± 0.9214.7 (12 - 24)10(35.7%)The MPV has a high sensitivity and specificity for establishing the
diagnosis of snit. In addition, it can be used as a predictor of mortality in preterm infants.		Low
Oncel, 2012 [19]TurkeyCase-control studyClinical and laboratory diagnosis8.57 ± 0.6727.4 (0.11–45.2)NRThe MPV values are significantly higher in patients with sepsis, proven or clinical, compared to healthy
controls.		High
Omran, 2017
[20]		EgyptCase-control studyClinical and laboratory diagnosis10.2 ± 1.2 fl27.3 ± 13.3 mg/LNRThe MPV, taking 10.2 fl as a cut-off point, is able to predict neonatal
sepsis with a sensitivity and
specificity of 80%.		Low
Mousa, 2021
[21]		EgyptCase-control studyClinical and laboratory diagnosis10.03 ± 0.6657.47 ± 56.9NRThe MPV is a cost-effective platelet parameter for predicting the diagnosis of neonatal sepsis.High
Karabulut, 2020
[22]		TurkeyCase-control studyClinical and laboratory diagnosis10.2 ± 0.8917.3 ± 6.6NRThe MPV is a biomarker, which at the cut-off value of 9.3 fl, has a sensitivity of 84% and a specificity of 32% for the diagnosis of EONS.Low
Madani, 2019
[23]		IranCase-control studyClinical diagnosis10.3 ± 0.23NRNRNewborns with sepsis have
significantly higher MPV values, with a sensitivity of 65.3% and a specificity of 75% for diagnosing this pathology.		High
Hanaganahalli 2018
[24]		IndiaCase-control studyClinical diagnosisGroup i = 9.56 ± 1.21
group ii = 8.86 ± 0.98		Group i = 66.95 ± 74.78
group ii = 18.01 ± 3.39		NRThe MPV, with a cutoff value ≥ 9.5 fl, can predict the diagnosis of neonatal sepsis with a sensitivity of 85% and a specificity of 56%.Low
Catal, 2014
[25]		TurkeyCase-control studyClinical diagnosis10.2 ± 0.55.7 (16.5)NRMPV is effective for the diagnosis and follow-up of neonatal sepsis in
preterm infants. However, it would not be useful for discriminating sepsis according to time of onset (early or late onset).		High
Aydin, 2014
[26]		TurkeyCase-control studyClinical and laboratory diagnosisGroup i = 10.6 ± 1.1
group ii = 10.4 ± 0.9		Group i = 33.0 ± 3.4
group ii = 54.6 ± 5.4		NRHigh MPV values were not associated with the development of sepsis, as this could be explained by the
increase of young platelets in the
circulation due to the destruction of platelets present in this pathology.		Low
Aydemir, 2018
[27]		Turkey Case-control studiesClinical and laboratory diagnosis8.4 (5.9–12.1)15.0 (0.0–200.0)42.0 (20.6)MPV values were found to be
significantly higher in preterm infants with sepsis. Furthermore, these values were higher in preterm infants with late-onset neonatal sepsis than in those with EONS.		Low
Shalaby, 2013 [28]EgyptCase-control studyClinical diagnosis10.4 ± 0.71 44.5 ± 12.6NAMPV could be assessed in the early diagnosis of neonatal sepsis while SUA level has lower sensitivity in
neonatal sepsis. 		Low
Yao, 2014 [29]ChinaRetrospective cohortClinical and laboratory diagnosis11.1 ± 1.15 5.1 ± 2.7NAThe diagnostic accuracy of CRP for neonatal sepsis is superior to those of the percentage of neutrophils and MPVLow
MPV: Mean platelet volume. CRP: C-Reactive Protein. PCT: Procalcitonin. CSF: Cerebrospinal fluid. ESR: Erythrocyte Sedimentation Rate. EONS: Early onset neonatal sepsis. NR: Not Reported.
Table
Table 2. Diagnosis accuracy between studies.
Table 2. Diagnosis accuracy between studies.
Author, YearCut-Off (fL)Sensitivity (%)Specificity (%)NPV (%)PPV (%)AUC
Shaaban, 2018 [18]8.697.14100NRNR0.971
Oncel, 2012 [19]NRNRNRNRNRNR
Omran, 2017 [20]10.28080NRNR0.873
Mousa, 2021 [21]10.561.188.1NRNR0.78
Karabulut, 2020 [22]9.3843266.655.20.666
Madani, 2019 [23]9.9565.37527.7831.810.73
Hanaganahalli 2018 [24]9.5568588.548.30.734
Catal, 2014 [25]10.7595.284NRNR0.944
Aydin, 2014 [26]NR82546376NR
Aydemir, 2018 [27]9.130.288.372.755.20.034
Shalaby, 2014 [28]10.2716359740.68
Yao, 2014 [29]11.440.588.4NRNRNR
NPV: Negative predictive value. PPV: Positive predictive value. AUC: Area under the curve. NR: Not Reported.
Table
Table 3. GRADE summary of findings table.
Table 3. GRADE summary of findings table.
Mean Platelet Volume Compared to Control in Early Onset Sepsis Detection
Bibliography:
Certainty AssessmentSummary of Findings
Participants
(Studies)
Follow-Up		Risk of BiasInconsistencyIndirectnessImprecisionPublication BiasOverall
Certainty of
Evidence		Study Event Rates (%)Relative Effect
(95% CI)		Anticipated Absolute Effects
With
Control 		With Mean Platelet
Volume		Risk with Control Risk Difference with Mean Platelet Volume
Mean Platelet Volume (Assessed with: fl)
1655
(10 observational studies)		very
serious a		very serious bnot seriousnot seriousnone⨁◯◯◯
Very low		798857-The mean platelet
volume was 0 fl		MD 1.38 fl higher
(1.01 higher to 1.76 higher)
CI: confidence interval; MD: mean difference. Explanations: a. ⨁ Decreases two levels because there are more than two studies with high risk of bias. b. ◯ Decreases two levels because heterogeneity is higher than 60%.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Toro-Huamanchumo, C.J.; Cabanillas-Ramirez, C.; Quispe-Vicuña, C.; Caballero-Alvarado, J.A.; León-Figueroa, D.A.; Cruces-Tirado, N.; Barboza, J.J. Mean Platelet Volume in Neonatal Sepsis: Meta-Analysis of Observational Studies. Children 2022, 9, 1821. https://doi.org/10.3390/children9121821

AMA Style

Toro-Huamanchumo CJ, Cabanillas-Ramirez C, Quispe-Vicuña C, Caballero-Alvarado JA, León-Figueroa DA, Cruces-Tirado N, Barboza JJ. Mean Platelet Volume in Neonatal Sepsis: Meta-Analysis of Observational Studies. Children. 2022; 9(12):1821. https://doi.org/10.3390/children9121821

Chicago/Turabian Style

Toro-Huamanchumo, Carlos J., Cielo Cabanillas-Ramirez, Carlos Quispe-Vicuña, Jose A. Caballero-Alvarado, Darwin A. León-Figueroa, Nicolás Cruces-Tirado, and Joshuan J. Barboza. 2022. "Mean Platelet Volume in Neonatal Sepsis: Meta-Analysis of Observational Studies" Children 9, no. 12: 1821. https://doi.org/10.3390/children9121821

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop